RADICAVA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is Edaravone.
Product ID | 70510-2171_26a8730f-518e-40d1-b695-536526c6a87b |
NDC | 70510-2171 |
Product Type | Human Prescription Drug |
Proprietary Name | RADICAVA |
Generic Name | Edaravone |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-05-05 |
Marketing Category | NDA / NDA |
Application Number | NDA209176 |
Labeler Name | Mitsubishi Tanabe Pharma America, Inc. |
Substance Name | EDARAVONE |
Active Ingredient Strength | 30 mg/100mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2017-05-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209176 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-05-05 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-03-12 |
Marketing Category | NDA |
Application Number | NDA209176 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-05-05 |
Marketing Category | NDA |
Application Number | NDA209176 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-05-05 |
Marketing End Date | 2017-11-14 |
Ingredient | Strength |
---|---|
EDARAVONE | 30 mg/100mL |
NDC | Brand Name | Generic Name |
---|---|---|
70510-2171 | RADICAVA | EDARAVONE |
70510-2172 | RADICAVA | edaravone |
70510-2321 | RADICAVA ORS | EDARAVONE |
70510-2322 | RADICAVA ORS | EDARAVONE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RADICAVA 87132086 5387607 Live/Registered |
Mitsubishi Tanabe Pharma Corporation 2016-08-09 |
RADICAVA 86863296 5277200 Live/Registered |
Mitsubishi Tanabe Pharma Corporation 2015-12-31 |